{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:52:50Z","timestamp":1791251570241,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-11-LABX-0021"],"award-info":[{"award-number":["ANR-11-LABX-0021"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"DOI":"10.1007\/s00125-026-06886-0","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:12:18Z","timestamp":1791202338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Visceral fat endocannabinoid overproduction is associated with insulin resistance and tissue dysfunction in mice and humans"],"prefix":"10.1007","author":[{"given":"Romain","family":"Barbosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-0741","authenticated-orcid":false,"given":"Julia","family":"Leemput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Passilly-Degrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9070-904X","authenticated-orcid":false,"given":"Oc\u00e9ane","family":"Pointeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Buch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-2283","authenticated-orcid":false,"given":"Jean-Paul Pais","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9829-6468","authenticated-orcid":false,"given":"Ma\u00e9va","family":"Loriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Lain\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Buet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7874-7743","authenticated-orcid":false,"given":"Pablo","family":"Ortega-Deballon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8957-629X","authenticated-orcid":false,"given":"Bruno","family":"Verg\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1749-2167","authenticated-orcid":false,"given":"Laurent","family":"Demizieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8127","authenticated-orcid":false,"given":"Tony","family":"Jourdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-2900","authenticated-orcid":false,"given":"Pascal","family":"Degrace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"7","key":"6886_CR1","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1053\/j.gastro.2019.12.054","volume":"158","author":"V Azzu","year":"2020","unstructured":"Azzu V, Vacca M, Virtue S, Allison M, Vidal-Puig A (2020) Adipose tissue\u2013liver cross talk in the control of whole-body metabolism: implications in nonalcoholic fatty liver disease. Gastroenterology 158(7):1899\u20131912. https:\/\/doi.org\/10.1053\/j.gastro.2019.12.054","journal-title":"Gastroenterology"},{"issue":"1","key":"6886_CR2","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1111\/obr.13521","volume":"24","author":"J Pan","year":"2023","unstructured":"Pan J, Yin J, Gan L, Xue J (2023) Two-sided roles of adipose tissue: rethinking the obesity paradox in various human diseases from a new perspective. Obes Rev 24(1):e13521. https:\/\/doi.org\/10.1111\/obr.13521","journal-title":"Obes Rev"},{"issue":"9112","key":"6886_CR3","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(05)79052-8","volume":"351","author":"P Arner","year":"1998","unstructured":"Arner P (1998) Not all fat is alike. Lancet 351(9112):1301\u20131302. https:\/\/doi.org\/10.1016\/S0140-6736(05)79052-8","journal-title":"Lancet"},{"issue":"1","key":"6886_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2012.10.001","volume":"34","author":"MJ Lee","year":"2013","unstructured":"Lee MJ, Wu Y, Fried SK (2013) Adipose tissue heterogeneity: implication of depot differences in adipose tissue for obesity complications. Mol Aspects Med 34(1):1\u201311. https:\/\/doi.org\/10.1016\/j.mam.2012.10.001","journal-title":"Mol Aspects Med"},{"issue":"2","key":"6886_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1365-2036.2011.04929.x","volume":"35","author":"S Petta","year":"2012","unstructured":"Petta S, Amato MC, Di Marco V et al (2012) Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 35(2):238\u2013247. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04929.x","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"6886_CR6","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3390\/ijms20092358","volume":"20","author":"M Longo","year":"2019","unstructured":"Longo M, Zatterale F, Naderi J et al (2019) Adipose tissue dysfunction as determinant of obesity-associated metabolic complications. Int J Mol Sci 20(9):2358. https:\/\/doi.org\/10.3390\/ijms20092358","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6886_CR7","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11154-020-09623-z","volume":"23","author":"KM Jung","year":"2022","unstructured":"Jung KM, Lin L, Piomelli D (2022) The endocannabinoid system in the adipose organ. Rev Endocr Metab Disord 23(1):51\u201360. https:\/\/doi.org\/10.1007\/s11154-020-09623-z","journal-title":"Rev Endocr Metab Disord"},{"issue":"19","key":"6886_CR8","doi-asserted-by":"publisher","first-page":"9549","DOI":"10.3390\/ijms26199549","volume":"26","author":"A Serefko","year":"2025","unstructured":"Serefko A, Lachowicz-Radulska J, Jach ME, Swiader K, Szopa A (2025) The endocannabinoid system in the development and treatment of obesity: searching for new ideas. Int J Mol Sci 26(19):9549. https:\/\/doi.org\/10.3390\/ijms26199549","journal-title":"Int J Mol Sci"},{"issue":"1","key":"6886_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-d","volume":"50","author":"R Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L et al (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50(1):83\u201390. https:\/\/doi.org\/10.1016\/0006-2952(95)00109-d","journal-title":"Biochem Pharmacol"},{"key":"6886_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","volume":"62","author":"FA Iannotti","year":"2016","unstructured":"Iannotti FA, Di Marzo V, Petrosino S (2016) Endocannabinoids and endocannabinoid-related mediators: targets, metabolism and role in neurological disorders. Prog Lipid Res 62:107\u2013128. https:\/\/doi.org\/10.1016\/j.plipres.2016.02.002","journal-title":"Prog Lipid Res"},{"key":"6886_CR11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1146\/annurev.biochem.74.082803.133450","volume":"74","author":"MK McKinney","year":"2005","unstructured":"McKinney MK, Cravatt BF (2005) Structure and function of fatty acid amide hydrolase. Annu Rev Biochem 74:411\u2013432. https:\/\/doi.org\/10.1146\/annurev.biochem.74.082803.133450","journal-title":"Annu Rev Biochem"},{"key":"6886_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0083-6729(09)81001-7","volume":"81","author":"Y Okamoto","year":"2009","unstructured":"Okamoto Y, Tsuboi K, Ueda N (2009) Enzymatic formation of anandamide. Vitam Horm 81:1\u201324. https:\/\/doi.org\/10.1016\/S0083-6729(09)81001-7","journal-title":"Vitam Horm"},{"issue":"5","key":"6886_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","volume":"45","author":"T Sugiura","year":"2006","unstructured":"Sugiura T, Kishimoto S, Oka S, Gokoh M (2006) Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 45(5):405\u2013446. https:\/\/doi.org\/10.1016\/j.plipres.2006.03.003","journal-title":"Prog Lipid Res"},{"key":"6886_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","volume":"80","author":"AC Howlett","year":"2017","unstructured":"Howlett AC, Abood ME (2017) CB1 and CB2 receptor pharmacology. Adv Pharmacol 80:169\u2013206. https:\/\/doi.org\/10.1016\/bs.apha.2017.03.007","journal-title":"Adv Pharmacol"},{"issue":"11","key":"6886_CR15","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.2337\/db06-0812","volume":"55","author":"M Bluher","year":"2006","unstructured":"Bluher M, Engeli S, Kloting N et al (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55(11):3053\u20133060. https:\/\/doi.org\/10.2337\/db06-0812","journal-title":"Diabetes"},{"issue":"2","key":"6886_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00125-008-1178-6","volume":"52","author":"V Di Marzo","year":"2009","unstructured":"Di Marzo V, Cote M, Matias I et al (2009) Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 52(2):213\u2013217. https:\/\/doi.org\/10.1007\/s00125-008-1178-6","journal-title":"Diabetologia"},{"issue":"1","key":"6886_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s13105-024-01063-6","volume":"81","author":"C Rodriguez-Garcia","year":"2025","unstructured":"Rodriguez-Garcia C, Osuna-Prieto FJ, Kohler I et al (2025) Higher plasma levels of endocannabinoids and analogues are correlated with a worse cardiometabolic profile in middle-aged adults. J Physiol Biochem 81(1):173\u2013184. https:\/\/doi.org\/10.1007\/s13105-024-01063-6","journal-title":"J Physiol Biochem"},{"issue":"10","key":"6886_CR18","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/s41366-024-01553-z","volume":"48","author":"N Mattelaer","year":"2024","unstructured":"Mattelaer N, Van der Schueren B, Van Oudenhove L, Weltens N, Vangoitsenhoven R (2024) The circulating and central endocannabinoid system in obesity and weight loss. Int J Obes (Lond) 48(10):1363\u20131382. https:\/\/doi.org\/10.1038\/s41366-024-01553-z","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"6886_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/can.2016.0","volume":"1","author":"I Matias","year":"2016","unstructured":"Matias I, Cota D (2016) The fat side of the endocannabinoid system: role of endocannabinoids in the adipocyte. Cannabis Cannabinoid Res 1(1):176\u2013185. https:\/\/doi.org\/10.1089\/can.2016.0","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"6886_CR20","doi-asserted-by":"publisher","first-page":"E26","DOI":"10.1152\/ajpendo.00374.2016","volume":"313","author":"T Muller","year":"2017","unstructured":"Muller T, Demizieux L, Troy-Fioramonti S et al (2017) Overactivation of the endocannabinoid system alters the antilipolytic action of insulin in mouse adipose tissue. Am J Physiol Endocrinol Metab 313(1):E26\u2013E36. https:\/\/doi.org\/10.1152\/ajpendo.00374.2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"Suppl 1","key":"6886_CR21","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","volume":"47","author":"AC Howlett","year":"2004","unstructured":"Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ (2004) Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47(Suppl 1):345\u2013358. https:\/\/doi.org\/10.1016\/j.neuropharm.2004.07.030","journal-title":"Neuropharmacology"},{"issue":"6","key":"6886_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/187152709789824615","volume":"8","author":"GD Dalton","year":"2009","unstructured":"Dalton GD, Bass CE, Van Horn CG, Howlett AC (2009) Signal transduction via cannabinoid receptors. CNS Neurol Disord Drug Targets 8(6):422\u2013431. https:\/\/doi.org\/10.2174\/187152709789824615","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"4","key":"6886_CR23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.cmet.2013.03.001","volume":"17","author":"C Silvestri","year":"2013","unstructured":"Silvestri C, Di Marzo V (2013) The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17(4):475\u2013490. https:\/\/doi.org\/10.1016\/j.cmet.2013.03.001","journal-title":"Cell Metab"},{"issue":"8","key":"6886_CR24","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim D, Paggi JM, Park C, Bennett C, Salzberg SL (2019) Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat Biotechnol 37(8):907\u2013915. https:\/\/doi.org\/10.1038\/s41587-019-0201-4","journal-title":"Nat Biotechnol"},{"issue":"3","key":"6886_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea M, Pertea GM, Antonescu CM, Chang TC, Mendell JT, Salzberg SL (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33(3):290\u2013295. https:\/\/doi.org\/10.1038\/nbt.3122","journal-title":"Nat Biotechnol"},{"issue":"12","key":"6886_CR26","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"issue":"3","key":"6886_CR27","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1194\/jlr.M065227","volume":"57","author":"LM Krott","year":"2016","unstructured":"Krott LM, Piscitelli F, Heine M et al (2016) Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation. J Lipid Res 57(3):464\u2013473. https:\/\/doi.org\/10.1194\/jlr.M065227","journal-title":"J Lipid Res"},{"issue":"6 Pt B","key":"6886_CR28","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1006\/nbdi.1998.0214","volume":"5","author":"V Di Marzo","year":"1998","unstructured":"Di Marzo V, Deutsch DG (1998) Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 5(6 Pt B):386\u2013404. https:\/\/doi.org\/10.1006\/nbdi.1998.0214","journal-title":"Neurobiol Dis"},{"issue":"3","key":"6886_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00232-005-0808-x","volume":"207","author":"SC Lee","year":"2005","unstructured":"Lee SC, Vielhauer NS, Leaver EV, Pappone PA (2005) Differential regulation of Ca2+ signaling and membrane trafficking by multiple P2 receptors in brown adipocytes. J Membr Biol 207(3):131\u2013142. https:\/\/doi.org\/10.1007\/s00232-005-0808-x","journal-title":"J Membr Biol"},{"issue":"4","key":"6886_CR30","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/sj.ijo.0803539","volume":"31","author":"M Cote","year":"2007","unstructured":"Cote M, Matias I, Lemieux I et al (2007) Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. Int J Obes (Lond) 31(4):692\u2013699. https:\/\/doi.org\/10.1038\/sj.ijo.0803539","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"6886_CR31","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1210\/clinem\/dgad668","volume":"109","author":"X Di","year":"2024","unstructured":"Di X, Martinez-Tellez B, Krekels EHJ et al (2024) Higher plasma levels of endocannabinoids and analogues correlate with a worse cardiometabolic profile in young adults. J Clin Endocrinol Metab 109(5):1351\u20131360. https:\/\/doi.org\/10.1210\/clinem\/dgad668","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"6886_CR32","doi-asserted-by":"publisher","first-page":"2838","DOI":"10.2337\/diabetes.54.10.2838","volume":"54","author":"S Engeli","year":"2005","unstructured":"Engeli S, Bohnke J, Feldpausch M et al (2005) Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54(10):2838\u20132843. https:\/\/doi.org\/10.2337\/diabetes.54.10.2838","journal-title":"Diabetes"},{"key":"6886_CR33","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1476-511X-10-194","volume":"10","author":"T You","year":"2011","unstructured":"You T, Disanzo BL, Wang X, Yang R, Gong D (2011) Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. Lipids Health Dis 10:194. https:\/\/doi.org\/10.1186\/1476-511X-10-194","journal-title":"Lipids Health Dis"},{"issue":"12","key":"6886_CR34","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1210\/jc.2007-0768","volume":"92","author":"C Pagano","year":"2007","unstructured":"Pagano C, Pilon C, Calcagno A et al (2007) The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. J Clin Endocrinol Metab 92(12):4810\u20134819. https:\/\/doi.org\/10.1210\/jc.2007-0768","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"6886_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/npp.2017.130","volume":"43","author":"CJ Hillard","year":"2018","unstructured":"Hillard CJ (2018) Circulating endocannabinoids: from whence do they come and where are they going? Neuropsychopharmacology 43(1):155\u2013172. https:\/\/doi.org\/10.1038\/npp.2017.130","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"6886_CR36","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1152\/physrev.00019.2008","volume":"89","author":"M Kano","year":"2009","unstructured":"Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M (2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89(1):309\u2013380. https:\/\/doi.org\/10.1152\/physrev.00019.2008","journal-title":"Physiol Rev"},{"issue":"4","key":"6886_CR37","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","volume":"98","author":"MC Petersen","year":"2018","unstructured":"Petersen MC, Shulman GI (2018) Mechanisms of insulin action and insulin resistance. Physiol Rev 98(4):2133\u20132223. https:\/\/doi.org\/10.1152\/physrev.00063.2017","journal-title":"Physiol Rev"},{"key":"6886_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.biochi.2015.10.024","volume":"125","author":"P Morigny","year":"2016","unstructured":"Morigny P, Houssier M, Mouisel E, Langin D (2016) Adipocyte lipolysis and insulin resistance. Biochimie 125:259\u2013266. https:\/\/doi.org\/10.1016\/j.biochi.2015.10.024","journal-title":"Biochimie"},{"issue":"5","key":"6886_CR39","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.2337\/db07-1186","volume":"57","author":"TM D'Eon","year":"2008","unstructured":"D\u2019Eon TM, Pierce KA, Roix JJ, Tyler A, Chen H, Teixeira SR (2008) The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 57(5):1262\u20131268. https:\/\/doi.org\/10.2337\/db07-1186","journal-title":"Diabetes"},{"issue":"8","key":"6886_CR40","doi-asserted-by":"publisher","first-page":"RC17","DOI":"10.1007\/BF03347440","volume":"30","author":"G Murdolo","year":"2007","unstructured":"Murdolo G, Kempf K, Hammarstedt A et al (2007) Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. J Endocrinol Invest 30(8):RC17-21. https:\/\/doi.org\/10.1007\/BF03347440","journal-title":"J Endocrinol Invest"},{"issue":"14","key":"6886_CR41","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1113\/jphysiol.2008.155903","volume":"586","author":"G Burnstock","year":"2008","unstructured":"Burnstock G (2008) Unresolved issues and controversies in purinergic signalling. J Physiol 586(14):3307\u20133312. https:\/\/doi.org\/10.1113\/jphysiol.2008.155903","journal-title":"J Physiol"},{"issue":"9","key":"6886_CR42","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1073\/pnas.0306707101","volume":"101","author":"A Witting","year":"2004","unstructured":"Witting A, Walter L, Wacker J, Moller T, Stella N (2004) P2X7 receptors control 2-arachidonoylglycerol production by microglial cells. Proc Natl Acad Sci USA 101(9):3214\u20133219. https:\/\/doi.org\/10.1073\/pnas.0306707101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"6886_CR43","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.3390\/molecules27061913","volume":"27","author":"M Rossato","year":"2022","unstructured":"Rossato M, Favaretto F, Granzotto M et al (2022) Molecular and pharmacological evidence for the expression of multiple functional P2 purinergic receptors in human adipocytes. Molecules 27(6):1913. https:\/\/doi.org\/10.3390\/molecules27061913","journal-title":"Molecules"},{"issue":"6","key":"6886_CR44","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2337\/db11-1389","volume":"61","author":"S Sun","year":"2012","unstructured":"Sun S, Xia S, Ji Y, Kersten S, Qi L (2012) The ATP\u2013P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 61(6):1471\u20131478. https:\/\/doi.org\/10.2337\/db11-1389","journal-title":"Diabetes"},{"issue":"8","key":"6886_CR45","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1210\/jc.2005-2679","volume":"91","author":"I Matias","year":"2006","unstructured":"Matias I, Gonthier MP, Orlando P et al (2006) Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J Clin Endocrinol Metab 91(8):3171\u20133180. https:\/\/doi.org\/10.1210\/jc.2005-2679","journal-title":"J Clin Endocrinol Metab"},{"key":"6886_CR46","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.molmet.2018.06.002","volume":"14","author":"F Fanelli","year":"2018","unstructured":"Fanelli F, Mezzullo M, Repaci A et al (2018) Profiling plasma N-acylethanolamine levels and their ratios as a biomarker of obesity and dysmetabolism. Mol Metab 14:82\u201394. https:\/\/doi.org\/10.1016\/j.molmet.2018.06.002","journal-title":"Mol Metab"},{"key":"6886_CR47","doi-asserted-by":"publisher","first-page":"680867","DOI":"10.1155\/2015\/680867","volume":"2015","author":"A Mallipedhi","year":"2015","unstructured":"Mallipedhi A, Prior SL, Dunseath G et al (2015) Changes in plasma levels of N-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis. J Diabetes Res 2015:680867. https:\/\/doi.org\/10.1155\/2015\/680867","journal-title":"J Diabetes Res"},{"key":"6886_CR48","doi-asserted-by":"publisher","first-page":"1076677","DOI":"10.3389\/fnut.2022.1076677","volume":"9","author":"N Soldevila-Domenech","year":"2022","unstructured":"Soldevila-Domenech N, Pastor A, Sala-Vila A et al (2022) Sex differences in endocannabinoids during 3 years of Mediterranean diet intervention: association with insulin resistance and weight loss in a population with metabolic syndrome. Front Nutr 9:1076677. https:\/\/doi.org\/10.3389\/fnut.2022.1076677","journal-title":"Front Nutr"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-026-06886-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-026-06886-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:06:28Z","timestamp":1791248788000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-026-06886-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":48,"alternative-id":["6886"],"URL":"https:\/\/doi.org\/10.1007\/s00125-026-06886-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"16 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors thank H. Choubley from UMS 058 BioSanD DiviOmics Lipidomic Analytical Platform for excellent technical assistance in the LC-MS\/MS analysis. We would also like to thank A. Degot (CHU Dijon Bourgogne) for her valuable contribution to patient recruitment, and I. Simoneau (CHU Dijon Bourgogne) for her contribution to the development of the study protocol. The graphical abstract was generated with the assistance of Perplexity AI, under the full supervision and validation of the authors.","order":1,"name":"Ethics","label":"Acknowledgements","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The clinical study protocol is registered and publicly accessible at ClinicalTrials.gov under the identifier NCT04940962. Raw RNA-seq transcriptomic data generated during this study have been deposited in the NCBI database under accession numbers SUB16040186 for human samples and SUB16182407 for mouse samples. All other supporting data associated with the findings of this manuscript are included within the main text or the ESM files.","order":2,"name":"Ethics","label":"Data availability","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This work was supported by grants from the Conseil R\u00e9gional Bourgogne Franche-Comt\u00e9, Universit\u00e9 Bourgogne Franche-Comt\u00e9, the Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale (Inserm) and by a French Government grant managed by the French National Research Agency under the programme \u2018Investissements d'Avenir\u2019 with reference ANR-11-LABX-0021 (Lipstic Labex).","order":3,"name":"Ethics","label":"Funding","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":4,"name":"Ethics","label":"Authors\u2019 relationships and activities","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"RB, JL, PP-D, CB, LD, TJ and PD participated in research design and conducted experiments and data analysis. J-PPdB performed and supervised the LC-MS\/MS analysis. PO-D and BV were responsible for the\u00a0overall coordination and management\u00a0of the clinical study as well as the interpretation of clinical data. OP, ML, LB and AL performed biochemical assays and analysed data. PD, RB, TJ, JL, PP-D and LD wrote or contributed to the writing of the manuscript. OP, CB, J-PPdB, ML, AL, LB, PO-D and BV critically reviewed the manuscript for important intellectual content. All authors gave final approval of the version to be published and agree to be accountable for all aspects of the work. PD is the guarantor of this work.","order":5,"name":"Ethics","label":"Contribution statement","group":{"name":"EthicsHeading","label":"Ethics"}}]}}